Transcript Document

Ganesh Iyer

Product Team Cialis Summary

Week 2, EWMBA 206 1

Part 1: Product Positioning Execution Toolkit Product Manager’s Positioning Strategy Toolkit

1:

For whom am I?

Identify the Target Consumer Segment.

For _____________, (

Target Market

) 2:

Who am I?

(value proposition, usp) our product/service is ______________________________________________ (

Most Important Claim/Unique Selling Proposition

) 3:

Why buy me?

(support) because ___________________

(Single Most Important Support)

4:

And not the competition?

(competitive set) among all ___________________ (

Competitive Set

)

Ganesh Iyer

2

The Four Positioning Questions

1.

For whom am I? (Target customer segment) 2.

Who am I? (Value proposition, USP) 3.

Why buy me? (Support) 4.

And not the competition? (Competitive Advantage)

Ganesh Iyer

3

Positioning a New Product in a Market with an Incumbent

 Where will demand come from? » increase primary category demand (new customers) » steal from competitors (existing customers of rival) » re-capture dissatisfied customers (not happy with existing brand/solution)  Which of the above segments are able to perceive as relevant a given way of positioning benefit/improvement? (Learning, Self-selection)  With whom can we leverage dimensions that are objectively measurable?

 With whom can we leverage dimensions that are not objectively measurable?

 Evolution of Positioning: » In what phase to target each segment? (Build category vs. build brand vs. protect brand)

Ganesh Iyer

4

Erectile Dysfunction Drugs – Vertical Positioning

A benefit associated with a performance or quality Attribute,

typically

objective, for which consumers differ in valuation.

Examples in Automobiles, PC, Retail Markets 36h 4h ~4h Viagra (Pfizer) Levitra (Bayer/GSK) Cialis (Lilly/Icos)

Ganesh Iyer

5

Erectile Dysfunction Drugs – Horizontal Positioning

A benefit that is a matter of “taste” or “attitude” often associated with psychographics, lifestyle, or underlying attitude

Naughty/Mischievous

Attitude towards sexual relationship

Romantic

Ganesh Iyer

6

Competition & Vertical vs. Horizontal Positioning of New Products

One firm at high end One firm at low end One firm offers benefit A -

Well defined objective benefit where more of is better

-

Consumers know how much improvement is worth to them

-Difference in willingness to pay for improvement -Segmentation based on tradeoff between particular benefit(s) and willingness to pay One firm offers benefit B

Ganesh Iyer

Price sensitivity not a primary issue -

More is not necessarily better for everyone

-

Heterogeneity in tastes, attitudes

7

Ganesh Iyer Leverage Unquantifiable Dimensions- Vertical

Reliability/Consistency/Count on it 8

Target Market Selection and the Incumbent Firm

Presence of Incumbent firm creates a new layer of segmentation (users, drop outs, never tried but aware, never tried not aware) =

Behavior- based segmentation

.

 Does dis-satisfaction with existing

=

high willingness to try something new?

 User of incumbent brand = hard to switch = last resort?  Who has advantage with those that never tried?

 How do other relevant parties/influencers factor in?

Ganesh Iyer

9

Evolving Positioning

Courage Sympathy Fight condition Building Category Macho Winning Success Building Brand

Ganesh Iyer

Excitement Wild Naughty Protecting Brand 10

Importance of Positioning

 Becoming more important in pharmaceuticals:  78% of drugs that entered the market in past six years were classified by FDA: » “not likely to be improvements over drugs already sold to treat the same condition”.

» Prevalence of lifestyle/Quality of life drugs 

Positioning is not what you do to the product but what you do to the mind of the consumer!

Ganesh Iyer

11

Positioning Strategies

 Product Quality: (Ford: Quality is job 1)  Class of Users: (Pepsi generation).

 Owning the category (Coke: The Real thing)  Against a Competitor (Avis) » Repositioning Hertz

Ganesh Iyer

12

Positioning Strategies

 Away from Competition (7-Up the Uncola)

Ganesh Iyer

13

ATTRIBUTE Good for snacks Good with meals For active people For mixing Good for indigestion Thirst quenching Good tasting

Ganesh Iyer Customer Analysis: Market Research Study

7Up 39 32 38 66 60 60 58 Coke 62 47 60 18 17 30 62 Pepsi 61 44 66 4 8 28 59

14

Options

 Tell consumers 7Up possesses soft drink attributes » point of parity (see also K&K p. 312-314).

 Emphasize fresh, clean taste (and no caffeine) » point of difference

Ganesh Iyer

15

Ganesh Iyer 7Up: “The Uncola”

16

Positioning Traps (1)

 Positioning on unimportant/irrelevant attributes

1992 Ganesh Iyer

17

Positioning Traps (2)

 Positioning with the wrong attributes Diet Beer  

Gablinger’s

Introduced in 1967 as a “low calorie” diet beer Lite beer by Miller  Less filling…means you can drink more!

» Everything you wanted in a beer » » (like getting drunk)…and less. 1/3 calories means you can drink 2 extra and call it even!

Ganesh Iyer

18

Positioning Traps (3)

 Positioning on someone else’s benefits…positioning is sticky  Burger King unable to claim “fast.” Already taken by McDonalds.

 Mercedes Benz and General Motors unable to claim “safety.” Already taken by Volvo.

Ganesh Iyer

19

Part 2: ED Market Updates: Global Performance Ganesh Iyer

• Is Cialis better off with or without DTC in the launch phase?

Country U.K.

Germany Italy France Spain Mexico Brazil USA Canada Australia Cialis 2003

®

Launch Date Share of PDE5 Market – Dec 2005 Cialis

®

Viagra

®

Levitra

® February February March February March August May November November February 26% 35% 36% 48% 29% 36% 38% 23% 31% 41% 66% 46% 47% 37% 48% 42% 45% 65% 62% 51% 8% 19% 17% 15% 23% 22% 17% 12% 7% 8% 20

Ganesh Iyer Cialis and ED Market- An Update

In the US 2004 ($1.03Billion) Viagra 65% ($672 million) Cialis 20% ($206.6million) Levitra 11% ($112 million) In the US 2005 ($1.1Billion) Viagra 61% ($665 million) Cialis 25% ($273million) Levitra 14% ($140 million) Worldwide 2004 Viagra $1.7Billion Cialis $552million Levitra $265 million Cialis in 2005 $746.6million

21

ED Market Competitive Reactions

 Advertising in the US first 11 months of 2004: » Viagra $98million » Cialis $151million » Levitra $147million  The “Cialis Promise” – Lilly gives men three free tablets of Cialis. If not satisfied Lilly will pay for three free tablets of Levitra or Viagra. If satisfied another round of Cialis. A Comparative Trial (92% ask for Cialis again)  Viagra “loyalty program” for every six prescriptions- get seventh free

Ganesh Iyer

22

ED Market Further Updates:

 Medical Experts: Men with ED problems = 30 million in US. Men who are interested in being treated probably half of that.

 Worldwide (a modest 5-10% increase in 2004, likewise in 2005)  Number of new prescriptions is going down in US: 10% fewer in October 05’ compared to October 04’   GlaxoSmithKline sold marketing rights outside the US back to Bayer consumer advertising is prohibited) – “The ED market hadn’t grown as fast as the company had hoped…tough to sell the drugs without the help of consumer ads” (in most of Europe direct-to Sexual performance drugs likely to be covered by Medicare’s new prescription benefit beginning next year (limited quantities, only when medically necessary).

 Lilly sets deal to acquire ICOS for $ 2.1 Bn.

Ganesh Iyer

23

Ganesh Iyer Competitive Advantages

» » » » First-Mover Advantages Lock customers in.

Association with category Network effects (among influencers, consumers) Economies of scale Second-Mover Advantages » Free-ride on first mover’s costs of educating the market » Learn from leader’s mistakes » Learn the market size » Parallel Entry Market may pay more attention when two companies are entering together.

– Benefit from increased category awareness 24

Learning

Positioning is not what you do to the product but what you do to the mind of the consumer!

Good Positioning is an integrated answer to 4 questions 1.

2.

3.

4.

For whom am I? (Target customer segment) Who am I? (value proposition, usp).

Why buy me? (support) And not the competition? (competitive advantage) Ganesh Iyer

25